Immunome, Inc. (IMNM)

Immunome Revenue

Immunome had revenue of $2.93M in the quarter ending March 31, 2025, with 184.35% growth. This brings the company's revenue in the last twelve months to $10.94M, down -13.76% year-over-year. In the year 2024, Immunome had annual revenue of $9.04M, down -35.50%.

• Revenue (ttm): $10.94M
• Revenue Growth: -13.76%
• P/S Ratio: 63.52
• Revenue / Employee: $92,695
• Employees: 118
• Market Cap: 921.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.04M	-4.98M	-35.50%
Dec 31, 2023	14.02M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.